These are the sources and citations used to research Health. This bibliography was generated on Cite This For Me on

  • Journal

    Attwood, M. M., Rask-Andersen, M. and Schiöth, H. B.

    Orphan Drugs and Their Impact on Pharmaceutical Development

    2018 - Trends in Pharmacological Sciences

    In-text: (Attwood, Rask-Andersen and Schiöth, 2018)

    Your Bibliography: Attwood, M., Rask-Andersen, M. and Schiöth, H., 2018. Orphan Drugs and Their Impact on Pharmaceutical Development. Trends in Pharmacological Sciences, 39(6), pp.525-535.

  • Journal

    Azoulay, P.

    Capturing Knowledge within and across Firm Boundaries: Evidence from Clinical Development

    2004 - American Economic Review

    In-text: (Azoulay, 2004)

    Your Bibliography: Azoulay, P., 2004. Capturing Knowledge within and across Firm Boundaries: Evidence from Clinical Development. American Economic Review, 94(5), pp.1591-1612.

  • Journal

    Banerjee, T. and Siebert, R.

    Dynamic impact of uncertainty on R&D cooperation formation and research performance: Evidence from the bio-pharmaceutical industry

    2017 - Research Policy

    In-text: (Banerjee and Siebert, 2017)

    Your Bibliography: Banerjee, T. and Siebert, R., 2017. Dynamic impact of uncertainty on R&D cooperation formation and research performance: Evidence from the bio-pharmaceutical industry. Research Policy, 46(7), pp.1255-1271.

  • Journal

    Berndt, E. R.

    Pharmaceuticals in U.S. Health Care: Determinants of Quantity and Price

    2002 - Journal of Economic Perspectives

    In-text: (Berndt, 2002)

    Your Bibliography: Berndt, E., 2002. Pharmaceuticals in U.S. Health Care: Determinants of Quantity and Price. Journal of Economic Perspectives, 16(4), pp.45-66.

  • Journal

    Danzon, P. and Pauly, M.

    Health Insurance and the Growth in Pharmaceutical Expenditures

    2002 - The Journal of Law and Economics

    In-text: (Danzon and Pauly, 2002)

    Your Bibliography: Danzon, P. and Pauly, M., 2002. Health Insurance and the Growth in Pharmaceutical Expenditures. The Journal of Law and Economics, 45(S2), pp.587-613.

  • Journal

    DiMasi, J. A., Grabowski, H. G. and Hansen, R. W.

    Innovation in the pharmaceutical industry: New estimates of R&D costs

    2016 - Journal of Health Economics

    In-text: (DiMasi, Grabowski and Hansen, 2016)

    Your Bibliography: DiMasi, J., Grabowski, H. and Hansen, R., 2016. Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics, 47, pp.20-33.

  • Journal

    Dunn, A.

    Drug Innovations and Welfare Measures Computed from Market Demand: The Case of Anti-Cholesterol Drugs

    2012 - American Economic Journal: Applied Economics

    In-text: (Dunn, 2012)

    Your Bibliography: Dunn, A., 2012. Drug Innovations and Welfare Measures Computed from Market Demand: The Case of Anti-Cholesterol Drugs. American Economic Journal: Applied Economics, 4(3), pp.167-189.

  • Journal

    Dunne, S., Shannon, B., Dunne, C. and Cullen, W.

    A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study

    2013 - BMC Pharmacology and Toxicology

    In-text: (Dunne, Shannon, Dunne and Cullen, 2013)

    Your Bibliography: Dunne, S., Shannon, B., Dunne, C. and Cullen, W., 2013. A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC Pharmacology and Toxicology, 14(1).

  • Journal

    Ellison, S. F., Cockburn, I., Griliches, Z. and Hausman, J.

    Characteristics of Demand for Pharmaceutical Products: An Examination of Four Cephalosporins

    1997 - The RAND Journal of Economics

    In-text: (Ellison, Cockburn, Griliches and Hausman, 1997)

    Your Bibliography: Ellison, S., Cockburn, I., Griliches, Z. and Hausman, J., 1997. Characteristics of Demand for Pharmaceutical Products: An Examination of Four Cephalosporins. The RAND Journal of Economics, 28(3), p.426.

  • Website

    Orphan designation: Overview - European Medicines Agency

    2021 - European Medicines Agency

    In-text: (Orphan designation: Overview - European Medicines Agency, 2021)

    Your Bibliography: European Medicines Agency. 2021. Orphan designation: Overview - European Medicines Agency. [online] Available at: <https://www.ema.europa.eu/en/human-regulatory/overview/orphan-designation-overview> [Accessed 8 January 2021].

  • Journal

    Frick, K. D. and Chernew, M. E.

    Beneficial Moral Hazard and the Theory of the Second Best

    2009 - INQUIRY: The Journal of Health Care Organization, Provision, and Financing

    In-text: (Frick and Chernew, 2009)

    Your Bibliography: Frick, K. and Chernew, M., 2009. Beneficial Moral Hazard and the Theory of the Second Best. INQUIRY: The Journal of Health Care Organization, Provision, and Financing, 46(2), pp.229-240.

  • Website

    Frost & Sullivan

    Global pharmaceutical market in-house vs outsourcing services share 2014-2023 Published by Matej Mikulic, Jan 15, 2020 Throughout the given period, the percentage of in-house spending is expected to decrease from 66.3 percent in 2014 to almost 51 percent in 2023. This statistic shows the percent distribution of in-house and outsourcing services expenditure in the global pharmaceutical market from 2014 to 2023. Distribution of in-house and outsourcing services expenditure in the global pharmaceutical market from 2014 to 2023

    2019

    In-text: (Frost & Sullivan, 2019)

    Your Bibliography: Frost & Sullivan, 2019. Global pharmaceutical market in-house vs outsourcing services share 2014-2023 Published by Matej Mikulic, Jan 15, 2020 Throughout the given period, the percentage of in-house spending is expected to decrease from 66.3 percent in 2014 to almost 51 percent in 2023. This statistic shows the percent distribution of in-house and outsourcing services expenditure in the global pharmaceutical market from 2014 to 2023. Distribution of in-house and outsourcing services expenditure in the global pharmaceutical market from 2014 to 2023. [online] https://www.statista.com/. Available at: <https://www-statista-com.eaccess.ub.tum.de/statistics/1085611/global-pharma-market-internal-vs-outsourced-services-expenditure-share/> [Accessed 4 January 2021].

  • Journal

    Grabowski, H., Brain, C., Taub, A. and Guha, R.

    Pharmaceutical Patent Challenges: Company Strategies and Litigation Outcomes

    2017 - American Journal of Health Economics

    In-text: (Grabowski, Brain, Taub and Guha, 2017)

    Your Bibliography: Grabowski, H., Brain, C., Taub, A. and Guha, R., 2017. Pharmaceutical Patent Challenges: Company Strategies and Litigation Outcomes. American Journal of Health Economics, 3(1), pp.33-59.

  • Journal

    Hellerstein, J. K.

    The Importance of the Physician in the Generic versus Trade-Name Prescription Decision

    1998 - The RAND Journal of Economics

    In-text: (Hellerstein, 1998)

    Your Bibliography: Hellerstein, J., 1998. The Importance of the Physician in the Generic versus Trade-Name Prescription Decision. The RAND Journal of Economics, 29(1), p.108.

  • Journal

    Iizuka, T.

    Experts' agency problems: evidence from the prescription drug market in Japan

    2008 - The RAND Journal of Economics

    In-text: (Iizuka, 2008)

    Your Bibliography: Iizuka, T., 2008. Experts' agency problems: evidence from the prescription drug market in Japan. The RAND Journal of Economics, 38(3), pp.844-862.

  • Journal

    Jayasundara, K., Hollis, A., Krahn, M., Mamdani, M., Hoch, J. S. and Grootendorst, P.

    Estimating the clinical cost of drug development for orphan versus non-orphan drugs

    2019 - Orphanet Journal of Rare Diseases

    In-text: (Jayasundara et al., 2019)

    Your Bibliography: Jayasundara, K., Hollis, A., Krahn, M., Mamdani, M., Hoch, J. and Grootendorst, P., 2019. Estimating the clinical cost of drug development for orphan versus non-orphan drugs. Orphanet Journal of Rare Diseases, 14(1).

  • Journal

    Kaier, K.

    The impact of pricing and patent expiration on demand for pharmaceuticals: an examination of the use of broad-spectrum antimicrobials

    2012 - Health Economics, Policy and Law

    In-text: (Kaier, 2012)

    Your Bibliography: Kaier, K., 2012. The impact of pricing and patent expiration on demand for pharmaceuticals: an examination of the use of broad-spectrum antimicrobials. Health Economics, Policy and Law, 8(1), pp.7-20.

  • Journal

    Kesselheim, A. S.

    Using Market-Exclusivity Incentives to Promote Pharmaceutical Innovation

    2010 - New England Journal of Medicine

    In-text: (Kesselheim, 2010)

    Your Bibliography: Kesselheim, A., 2010. Using Market-Exclusivity Incentives to Promote Pharmaceutical Innovation. New England Journal of Medicine, 363(19), pp.1855-1862.

  • Journal

    Lakdawalla, D. N.

    Economics of the Pharmaceutical Industry

    2018 - Journal of Economic Literature

    In-text: (Lakdawalla, 2018)

    Your Bibliography: Lakdawalla, D., 2018. Economics of the Pharmaceutical Industry. Journal of Economic Literature, 56(2), pp.397-449.

  • Presentation or lecture

    Leerapan, B.

    International Health Systems: The Western

    2014 - Mahidol University, Thailand

    In-text: (Leerapan, 2014)

    Your Bibliography: Leerapan, B., 2014. International Health Systems: The Western.

  • Journal

    Limbrock, F.

    Pecuniary and Non-Pecuniary Incentives in Prescription Pharmaceuticals: The Case of Statins

    2011 - The B.E. Journal of Economic Analysis & Policy

    In-text: (Limbrock, 2011)

    Your Bibliography: Limbrock, F., 2011. Pecuniary and Non-Pecuniary Incentives in Prescription Pharmaceuticals: The Case of Statins. The B.E. Journal of Economic Analysis & Policy, 11(2).

  • Journal

    Liu, S. and Chollet, D.

    Price and Income Elasticity of the Demand for Health Insurance and Health Care Services: A Critical Review of the Literature

    2006 - Mathematica Policy Research Reports

    In-text: (Liu and Chollet, 2006)

    Your Bibliography: Liu, S. and Chollet, D., 2006. Price and Income Elasticity of the Demand for Health Insurance and Health Care Services: A Critical Review of the Literature. Mathematica Policy Research Reports, [online] Available at: <https://EconPapers.repec.org/RePEc:mpr:mprres:dbf03ba11863430593b0b825fb48acc2.> [Accessed 10 January 2021].

  • Journal

    Luzzatto, L., Hyry, H. I., Schieppati, A., Costa, E., Simoens, S., Schaefer, F., Roos, J. C. P., Merlini, G., Kääriäinen, H., Garattini, S., Hollak, C. E., Remuzzi, G., Barbui, T., Benigni, A., Costa, E., Daina, E., Garattini, S., Gramaglia, D., Hollak, C. E. M., Hyry, H., Kaarinen, H., Licht, C., Luzzatto, L., Merlini, G., Notaro, R., Remuzzi, G., Schaefer, F., Schieppati, A. and Simoens, S.

    Outrageous prices of orphan drugs: a call for collaboration

    2018 - The Lancet

    In-text: (Luzzatto et al., 2018)

    Your Bibliography: Luzzatto, L., Hyry, H., Schieppati, A., Costa, E., Simoens, S., Schaefer, F., Roos, J., Merlini, G., Kääriäinen, H., Garattini, S., Hollak, C., Remuzzi, G., Barbui, T., Benigni, A., Costa, E., Daina, E., Garattini, S., Gramaglia, D., Hollak, C., Hyry, H., Kaarinen, H., Licht, C., Luzzatto, L., Merlini, G., Notaro, R., Remuzzi, G., Schaefer, F., Schieppati, A. and Simoens, S., 2018. Outrageous prices of orphan drugs: a call for collaboration. The Lancet, 392(10149), pp.791-794.

  • Journal

    Morgan, M. R., Roberts, O. G. and Edwards, A. M.

    Ideation and implementation of an open science drug discovery business model – M4K Pharma

    2018 - Wellcome Open Research

    In-text: (Morgan, Roberts and Edwards, 2018)

    Your Bibliography: Morgan, M., Roberts, O. and Edwards, A., 2018. Ideation and implementation of an open science drug discovery business model – M4K Pharma. Wellcome Open Research, 3, p.154.

  • Online image or video

    partners4access

    Dear orphan drug industry, are you prepared?

    2018

    In-text: (partners4access, 2018)

    Your Bibliography: partners4access, 2018. Dear orphan drug industry, are you prepared?. [image] Available at: <https://partners4access.com/wp-content/uploads/2018/02/infographic.png> [Accessed 8 January 2021].

  • Journal

    Rao, A.

    Entry and Investment Decisions in the Pharmaceutical Industry

    2015 - SSRN Electronic Journal

    In-text: (Rao, 2015)

    Your Bibliography: Rao, A., 2015. Entry and Investment Decisions in the Pharmaceutical Industry. SSRN Electronic Journal,.

  • Journal

    Ridley, D. B.

    PAYMENTS, PROMOTION, AND THE PURPLE PILL

    2013 - Health Economics

    In-text: (Ridley, 2013)

    Your Bibliography: Ridley, D., 2013. PAYMENTS, PROMOTION, AND THE PURPLE PILL. Health Economics, 24(1), pp.86-103.

  • Book

    Ringel, J. S., Hosek, S. D., Vollaard, B. A. and Mahnovski, S.

    The Elasticity of Demand for Health Care: A Review of the Literature and Its Application to the Military Health System

    2002 - RAND Corporation - Santa Monica, CA

    In-text: (Ringel, Hosek, Vollaard and Mahnovski, 2002)

    Your Bibliography: Ringel, J., Hosek, S., Vollaard, B. and Mahnovski, S., 2002. The Elasticity of Demand for Health Care: A Review of the Literature and Its Application to the Military Health System. Santa Monica, CA: RAND Corporation.

  • Journal

    Rudy, B. C. and Black, S. L.

    Attack or Defend? The Role of Institutional Context on Patent Litigation Strategies

    2015 - Journal of Management

    In-text: (Rudy and Black, 2015)

    Your Bibliography: Rudy, B. and Black, S., 2015. Attack or Defend? The Role of Institutional Context on Patent Litigation Strategies. Journal of Management, 44(3), pp.1226-1249.

  • Online image or video

    SB, C. M., Puranik, S., Sagar, P., Sreenivasa, S. and Rao, M. C.

    Patent process

    2014

    In-text: (SB et al., 2014)

    Your Bibliography: SB, C., Puranik, S., Sagar, P., Sreenivasa, S. and Rao, M., 2014. Patent process. [image] Available at: <https://www.rroij.com/open-access/patents--an-important-tool-for-pharmaceutical-industry-.php?aid=34351> [Accessed 8 January 2021].

  • Journal

    Scherer, F.

    Chapter 25 The pharmaceutical industry

    2000 - Handbook of Health Economics

    In-text: (Scherer, 2000)

    Your Bibliography: Scherer, F., 2000. Chapter 25 The pharmaceutical industry. Handbook of Health Economics, 1, pp.1297-1336.

  • Journal

    Scott Morton, F. and Kyle, M.

    Chapter Twelve - Markets for Pharmaceutical Products

    2011 - Handbook of Health Economics

    In-text: (Scott Morton and Kyle, 2011)

    Your Bibliography: Scott Morton, F. and Kyle, M., 2011. Chapter Twelve - Markets for Pharmaceutical Products. Handbook of Health Economics, 2, pp.763-823.

  • Journal

    Thiers, F. A., Sinskey, A. J. and Berndt, E. R.

    Trends in the globalization of clinical trials

    2008 - Nature Reviews Drug Discovery

    In-text: (Thiers, Sinskey and Berndt, 2008)

    Your Bibliography: Thiers, F., Sinskey, A. and Berndt, E., 2008. Trends in the globalization of clinical trials. Nature Reviews Drug Discovery, 7(1), pp.13-14.

  • Website

    How U.S. Health Insurance Works | Vaden Health Services

    2021

    In-text: (How U.S. Health Insurance Works | Vaden Health Services, 2021)

    Your Bibliography: Vaden.stanford.edu. 2021. How U.S. Health Insurance Works | Vaden Health Services. [online] Available at: <https://vaden.stanford.edu/insurance/health-insurance-overview/how-us-health-insurance-works> [Accessed 10 January 2021].

Click here to start building your own bibliography
Keep on Citing!
Cite This For Me:
The Easiest Tool to Create your Bibliographies Online
Join Us!

Save Time and Improve Your Marks with Cite This For Me

10,587 students joined last month!

  • ✔ Save your bibliographies for longer
  • ✔ Quick and accurate citation program
  • ✔ Save time when referencing
  • ✔ Make your student life easy and fun
  • ✔ Pay only once with our Forever plan
  • ✔ Use plagiarism checker
  • ✔ Create and edit multiple bibliographies
Join